伪酸B通过向CDK1来诱导狗乳腺瘤细胞的G2/M阶段停止
Mengjuan Chen1,2, Hui Han1,2, Mengke Qin1,2
1College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China.
Frontiers in veterinary science
|October 27, 2025
概括
伪酸B (PAB) 通过降低癌细胞活力和触发亡,在治疗犬乳腺瘤方面表现有前途. 这种化合物向CDK1,为犬乳腺瘤提供了潜在的新治疗策略.
科学领域:
- 兽医瘤学 兽医瘤学
- 分子药理学分子药理学
- 癌症生物学 癌症生物学
背景情况:
- 目前用于犬乳腺瘤 (CMT) 的治疗方法,如手术和化疗,具有局限性,包括高复发率和毒性.
- 需要新的,更安全,更有效的CMT治疗剂.
- 伪酸B (PAB) 是一种天然化合物,具有广泛的抗瘤活性和有利的药理动力学特征.
研究的目的:
- 为了研究PAB对犬乳腺瘤U27细胞的抗癌作用.
- 阐明PAB在CMT中的作用的基础分子机制.
主要方法:
- 在实验室中,细胞活力,增殖和亡的测定是在用PAB治疗的CMT U27细胞上进行的.
- 转录形状分析被用来分析PAB治疗细胞中的基因表达变化.
- 研究了PAB与CDK1的相互作用及其对细胞周期进展的影响.
主要成果:
- PAB剂量依赖性降低了犬乳腺瘤细胞活力和增殖.
- 在CMT细胞中,PAB诱导了卡斯巴酶介导的亡.
- PAB抑制了CDK1的表达和稳定性,导致G2/M阶段的停止和线粒细胞进展的抑制.
结论:
- 在实验室中,PAB对狗乳腺瘤细胞表现出显著的抗癌作用.
- CDK1被确定为CMT中PAB的关键分子标.
- PAB代表了对犬乳腺瘤的潜在治疗候选者,可能是针对CDK1.1的组合疗法.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.5K
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
2.3K
相关概念视频
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Negative Regulator Molecules
38.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
DNA Damage can Stall the Cell Cycle
10.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.0K
DNA Damage Can Stall the Cell Cycle
3.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
